Evolving management of patients treated by drug-eluting stent: Prevention of late events

Evolving management of patients treated by drug-eluting stent: Prevention of late events

Diğer sürümleri göster (1)

Summary: Drug eluting stents (DES) were introduced in clinical practice to overcome the problem of in-stent restenosis (ISR) that limited the overall efficacy of percutaneous coronary revascularization with bare metal stent (BMS). Long-term outcome data confirm a sustained benefit of DES as compared...

Detaylı Bibliyografya
Asıl Yazarlar:	Niccoli, G, Sgueglia, G, Montone, R, Roberto, M, Banning, A, Crea, F
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2014

Benzer Materyaller

Evolving management of patients treated by drug-eluting stent: prevention of late events.
Yazar:: Niccoli, G, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Which patients receiving warfarin can be treated safely with a drug-eluting stent?
Yazar:: Ryding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Yazar:: Porto, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
Yazar:: Schrale, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.
Yazar:: Mack, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Treatment of spontaneous coronary dissection with drug-eluting stents--late clinical, angiographic and IVUS follow up.
Yazar:: van Gaal, W, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Thrombotic occlusion of a drug-eluting stent - is IVUS mandatory.
Yazar:: Arnold, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Studies of biodegradable drug-eluting tracheal stents
Yazar:: Ng, Anthony Herr Cheun
Baskı/Yayın Bilgisi: (2012)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
Yazar:: Blackman, D, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Safety of MRI early after implantation of a drug-eluting stent.
Yazar:: Porto, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?
Yazar:: Takahashi, Saeko, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

A novel bioabsorbable drug-eluting tracheal stent
Yazar:: Zhu, G. H., ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Comparing long-term antiplatelet strategies to prevent morbidity and mortality in patients with drug-eluting coronary stents
Yazar:: Evans, J. Stewart (James Stewart)
Baskı/Yayın Bilgisi: (2011)

Intravascular ultrasound imaging in the diagnosis and treatment of spontaneous coronary dissection with drug-eluting stents.
Yazar:: Porto, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Drug deposition in coronary arteries with overlapping drug-eluting stents
Yazar:: Olgac, Ufuk, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

A bilayer swellable drug-eluting ureteric stent : localized drug delivery to treat urothelial diseases
Yazar:: Lim, Wei Shan, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Drug eluting stents in left main stem stenosis: patients will pay the price.
Yazar:: Taggart, D
Baskı/Yayın Bilgisi: (2007)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
Yazar:: Blackman, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
Yazar:: De Caterina, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Numerical modeling of local pharmacokinetics associated with drug-eluting stent
Yazar:: Jahid Ferdous
Baskı/Yayın Bilgisi: (2009)

Stent elution rate determines drug deposition and receptor-mediated effects
Yazar:: Tzafriri, Abraham R., ve diğerleri
Baskı/Yayın Bilgisi: (2016)

No-reflow: again prevention is better than treatment.
Yazar:: Niccoli, G, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
Yazar:: Abizaid, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
Yazar:: Fong, Timothy Ren Zhong
Baskı/Yayın Bilgisi: (2015)

The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns.
Yazar:: Taggart, D
Baskı/Yayın Bilgisi: (2008)

Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis.
Yazar:: Testa, L, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation.
Yazar:: Porto, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Yazar:: Dawkins, K, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
Yazar:: Mohd Shah, Azarisman Shah, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A novel expandable drug-eluting ureteric stent for the treatment of urological disorder
Yazar:: Tan, Jun Xiang
Baskı/Yayın Bilgisi: (2020)

Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
Yazar:: Zhu, Xiaoxiang, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Attempted retrograde reopening of an occluded left main stent.
Yazar:: Niccoli, G, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.
Yazar:: Dawkins, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
Yazar:: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Baskı/Yayın Bilgisi: (2015)

Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies)
Yazar:: Lansky, Alexandra J., ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Drug-eluting balloons: what is their place on the interventionalist's shelf?
Yazar:: Banning, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification.
Yazar:: Douglas, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

One-year outcome of small-vessel disease treated with sirolimus-eluting stents: a subgroup analysis of the e-SELECT registry.
Yazar:: Gao, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

One-year outcome of small-vessel disease treated with sirolimus-eluting stents: A subgroup analysis of the e-select registry
Yazar:: Gao, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
Yazar:: Tanabe, K, ve diğerleri
Baskı/Yayın Bilgisi: (2005)